E-COMMODITIES (01733) announced that the net profit attributable to equity shareholders for 2025 was HK$316 million, a decrease of 65.74% year-on-year.
China Merchants (01733) announced its performance for 2025, with a profit of HK$25.241 billion, a decrease of 35.55% year-on-year; net profit attributable to equity shareholders of the company was HK$316 million, a decrease of 65.74% year-on-year; basic and diluted earnings per share were HK$0.120, and the final dividend per share was HK$0.03.
E-COMMODITIES (01733) announced its performance in 2025 with revenue of HK$25.241 billion, a year-on-year decrease of 35.55%; net profit attributable to equity shareholders of the company was HK$316 million, a year-on-year decrease of 65.74%; earnings per share on a basic and diluted basis were both HK$0.120, with a final dividend of HK$0.03 per share.
The announcement stated that the main reason for the performance change was due to the sharp fluctuations in the coking coal market throughout the year, with a significant downward shift in prices, leading to a restructuring of the industry chain's profit, causing pressures on both the intermediary trade and logistics links, and extreme compression of profit margins.
Related Articles

VALA (02051) announced its performance in 2025, with adjusted net loss of 98.506 million yuan, an increase of 141.6% year-on-year.

CM-ENERGY (00206) reported annual earnings, with a net profit attributable to shareholders of 1.58 million US dollars, a decrease of 82.75% year-on-year.

SANAI HEALTH GP (01889) issues profit warning, expecting a loss of about 25.5 million to 27.5 million yuan for the year 2025.
VALA (02051) announced its performance in 2025, with adjusted net loss of 98.506 million yuan, an increase of 141.6% year-on-year.

CM-ENERGY (00206) reported annual earnings, with a net profit attributable to shareholders of 1.58 million US dollars, a decrease of 82.75% year-on-year.

SANAI HEALTH GP (01889) issues profit warning, expecting a loss of about 25.5 million to 27.5 million yuan for the year 2025.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


